The second-generation of drug-eluting stent (DES) technology is now reality in the U.S. Medtronic (Minneapolis) in early February reported FDA approval of the Endeavor DES, making it the first in the DES 2.0 family of these devices to win marketing okay in the U.S.
Browse by Speciality Area